8-K filing — Twist Bioscience Corp (TWST)
Filed: 2026-08-19 AccNo: 0001104659-26-098830 Size: 214 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Twist Bioscience Sees AI Drug Discovery Pipeline Expand
Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discovery and NGS businesses show growth.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 3, 2026, 4:13 PM
- Checked
- Aug 3, 2026, 4:13 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report
TWST shares surge after Anthropic names the company an independent evaluator in a new AI-driven protein design campaign. The bullish momentum overshadows a critical short report published on X by activist short-seller Scorpion Capital.
Read original at benzingaWatching Twist Bioscience; Scorpion Capital Issues Report On Co, States They Hold A Short Position
https://x.com/ScorpionFund/status/2090160099520348644?s=20
Read original at benzingaTwist Bioscience Stock Hits 52-Week High - Here's Why
Twist Bioscience (TWST) stock jumped 17% after Anthropic chose the firm to test AI-designed proteins. Get the full market update.
Read original at benzinga